DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
DNA methyltransferase inhibition increases efficacy of adoptive cellular immunotherapy of murine breast cancer
Authors
Keywords
T lymphocytes, Immunotherapy, Decitabine, Epigenetic, Myeloid derived suppressor cells
Journal
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 65, Issue 9, Pages 1061-1073
Publisher
Springer Nature
Online
2016-07-14
DOI
10.1007/s00262-016-1868-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2015
- (2015) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Augmenting Antitumor Immune Responses with Epigenetic Modifying Agents
- (2015) Erika Héninger et al. Frontiers in Immunology
- Eradication of metastatic mouse cancers resistant to immune checkpoint blockade by suppression of myeloid-derived cells
- (2014) K. Kim et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Decitabine facilitates immune recognition of sarcoma cells by upregulating CT antigens, MHC molecules, and ICAM-1
- (2014) Deepa Kolaseri Krishnadas et al. TUMOR BIOLOGY
- Epigenetic Potentiation of NY-ESO-1 Vaccine Therapy in Human Ovarian Cancer
- (2014) K. Odunsi et al. Cancer Immunology Research
- Tumor immunology and cancer immunotherapy: summary of the 2013 SITC primer
- (2014) Raju R Raval et al. Journal for ImmunoTherapy of Cancer
- Fractal Organization of the Human T Cell Repertoire in Health and after Stem Cell Transplantation
- (2013) Jeremy Meier et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Peripheral blood mononuclear cells of patients with breast cancer can be reprogrammed to enhance anti-HER-2/neu reactivity and overcome myeloid-derived suppressor cells
- (2013) Kyle K. Payne et al. BREAST CANCER RESEARCH AND TREATMENT
- Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trial
- (2013) Christoph Domschke et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
- (2013) D. Alizadeh et al. CANCER RESEARCH
- Myeloid-Derived Suppressor Cells Suppress Antitumor Immune Responses through IDO Expression and Correlate with Lymph Node Metastasis in Patients with Breast Cancer
- (2013) J. Yu et al. JOURNAL OF IMMUNOLOGY
- Molecular signatures mostly associated with NK cells are predictive of relapse free survival in breast cancer patients
- (2013) Maria Ascierto et al. Journal of Translational Medicine
- Circulating and Tumor-Infiltrating Myeloid-Derived Suppressor Cells in Patients with Colorectal Carcinoma
- (2013) Bin Zhang et al. PLoS One
- Epigenetic induction of adaptive immune response in multiple myeloma: sequential azacitidine and lenalidomide generate cancer testis antigen-specific cellular immunity
- (2012) Amir A. Toor et al. BRITISH JOURNAL OF HAEMATOLOGY
- Differential effects of low-dose decitabine on immune effector and suppressor responses in melanoma-bearing mice
- (2012) Pierre L. Triozzi et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Immunotherapy augments the effect of 5-azacytidine on HPV16-associated tumours with different MHC class I-expression status
- (2011) J Šímová et al. BRITISH JOURNAL OF CANCER
- Improving T-cell Therapy for Relapsed EBV-Negative Hodgkin Lymphoma by Targeting Upregulated MAGE-A4
- (2011) C. R. Cruz et al. CLINICAL CANCER RESEARCH
- Strategies to counteract MHC-I defects in tumors
- (2011) Margit H Lampen et al. CURRENT OPINION IN IMMUNOLOGY
- ADAM10 Overexpression Shifts Lympho- and Myelopoiesis by Dysregulating Site 2/Site 3 Cleavage Products of Notch
- (2011) David R. Gibb et al. JOURNAL OF IMMUNOLOGY
- Establishment and Large-scale Expansion of Minimally cultured “Young” Tumor Infiltrating Lymphocytes for Adoptive Transfer Therapy
- (2011) Orit Itzhaki et al. JOURNAL OF IMMUNOTHERAPY
- Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure
- (2011) Maciej Kmieciak et al. Journal of Translational Medicine
- Phenotype, functions and fate of adoptively transferred tumor draining lymphocytes activated ex vivo in mice with an aggressive weakly immunogenic mammary carcinoma
- (2010) Catriona HT Miller et al. BMC IMMUNOLOGY
- Clinical Responses in a Phase II Study Using Adoptive Transfer of Short-term Cultured Tumor Infiltration Lymphocytes in Metastatic Melanoma Patients
- (2010) M. J. Besser et al. CLINICAL CANCER RESEARCH
- IL-7 + IL-15 are superior to IL-2 for the ex vivo expansion of 4T1 mammary carcinoma-specific T cells with greater efficacy against tumors in vivo
- (2009) Esther Cha et al. BREAST CANCER RESEARCH AND TREATMENT
- Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2′-deoxycytidine
- (2009) Irina Daurkin et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Adoptive transfer of HER2/neu-specific T cells expanded with alternating gamma chain cytokines mediate tumor regression when combined with the depletion of myeloid-derived suppressor cells
- (2008) Johanna K. Morales et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search